Ashley A. Vo, PharmD, is the Administrative Director of the Transplant Immunotherapy Program at the Comprehensive Transplant Center at Cedars-Sinai Medical Center in Los Angeles, California and Professor of Pediatrics at the David Geffen School of Medicine at UCLA. Dr. Vo earned her Doctor of Pharmacy degree at the University of Southern California in Los Angeles. She completed a General Practice Residency and a Specialty Residency in Administration, both at Cedars-Sinai Medical Center. Dr. Vo’s research has been in advancing the field of desensitization for the highly HLA sensitized patients awaiting kidney transplantation and the development of novel therapeutics for prevention and treatment of antibody mediated rejection in kidney transplantation. Dr. Vo is a Co-Investigator for all Kidney Transplant Investigator Initiated Trials and Industry sponsored trials, serves as an ad hoc reviewer for Transplantation, American Journal of Transplantation, Journal of Immunology, etc. and has published in journals including Transplantation, American Journal of Transplantation, World Journal of Nephrology, and Immunotherapy. Dr. Vo was awarded AST Clinician of Distinction in 2014, a prestigious award that recognizes clinical excellence and the creative scholarship brings to the field of transplantation, and Fellow of the American Society of Transplant in 2016.